Krystal Biotech
KRYS
#2066
Rank
NZ$17.02 B
Marketcap
NZ$574.45
Share price
5.62%
Change (1 day)
58.78%
Change (1 year)

Earnings for Krystal Biotech (KRYS)

Earnings in 2026 (TTM): NZ$0.39 Billion

According to Krystal Biotech's latest financial reports the company's current earnings are NZ$0.47 Billion. In 2025 the company made an earning of NZ$0.29 Billion, an increase over its 2024 earnings that were of NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Krystal Biotech from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.39 B35.76%
2025 NZ$0.29 B56.24%
2024 NZ$0.18 B700.38%
2023 NZ$23.49 M-110.98%
2022 -NZ$0.22 Billion72.56%
2021 -NZ$0.13 Billion111.4%
2020 -NZ$58.67 Million45.85%
2019 -NZ$40.23 Million85.28%
2018 -NZ$21.71 Million149.78%
2017 -NZ$8.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-168.63%๐Ÿ‡บ๐Ÿ‡ธ USA